Compare SRBK & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRBK | INMB |
|---|---|---|
| Founded | 1887 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7M | 42.5M |
| IPO Year | N/A | 2019 |
| Metric | SRBK | INMB |
|---|---|---|
| Price | $16.63 | $1.70 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 32.8K | ★ 365.6K |
| Earning Date | 01-29-2026 | 10-30-2025 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | ★ 374.69 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $31,130,000.00 | $50,000.00 |
| Revenue This Year | N/A | $264.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $30.81 | ★ N/A |
| Revenue Growth | 0.85 | ★ 19.05 |
| 52 Week Low | $11.36 | $1.38 |
| 52 Week High | $17.11 | $11.64 |
| Indicator | SRBK | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 52.03 |
| Support Level | $16.35 | $1.58 |
| Resistance Level | $17.10 | $1.72 |
| Average True Range (ATR) | 0.40 | 0.10 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 69.88 | 81.82 |
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.